You are here

diabetes

Sanofi-Aventis to Pay as Much as $335 Million for CureDM Diabetes Drug

Bloomberg

Thu, 04/8/10 - 09:03 am

NVO's Victoza More Effective

Yahoo/Zacks.com

Wed, 03/31/10 - 10:05 am

Saudi Arabia Suspends Avandia Diabetes Pill

Pharmalot

Mon, 03/22/10 - 09:58 am

Diabetes Drug Supporters Had Financial Tie to Glaxo, Study Says

Bloomberg

Fri, 03/19/10 - 08:33 am

Has Roche Given Up On Diabetes Devices?

Forbes

Thu, 03/18/10 - 03:57 pm

More Delays on MannKind's Inhaled Insulin: The Pros and Cons

BNET Pharma

Thu, 03/18/10 - 08:15 am

inhaled insulin

Bristol combination diabetes drug under review

Yahoo/AP

Wed, 03/17/10 - 11:00 am

Bristol-Myers Squibb

FDA Says "No Way!" Market Says "Yeah, Baby!"(Byetta)

Motley Fool

Mon, 03/15/10 - 04:20 pm

Novartis Heart, Diabetes Drugs Fail to Prevent Disease in Study

Bloomberg

Mon, 03/15/10 - 12:01 pm

Amylin, Alkermes Gain as FDA Doesn’t Need More Byetta Data

Bloomberg

Mon, 03/15/10 - 11:49 am

Studies: Intense treatment doesn't help diabetics

Yahoo/AP

Mon, 03/15/10 - 10:15 am

Abbott Laboratories

Amylin shares fall ahead of diabetes drug decision

Yahoo/AP

Thu, 03/11/10 - 06:17 pm

Transition Therapeutics and Lilly in diabetes deal

Yahoo/AP

Wed, 03/3/10 - 11:42 am

Transition Therapeutics

California County Sues Glaxo Over Avandia Risks

Pharmalot

Mon, 03/1/10 - 09:54 am

Diabetes Rivals Lick Chops Over Avandia Setback

Forbes

Tue, 02/23/10 - 10:47 am

Senate Report: Glaxo Knew of Avandia Risks

The Street

Sun, 02/21/10 - 10:58 am

Controversial Diabetes Drug (Avandia) Harms Heart, U.S. Concludes

NY Times

Sat, 02/20/10 - 11:56 am

AstraZeneca Faces First Trial Over Seroquel Diabetes Claims

Bloomberg

Thu, 02/18/10 - 11:10 am

Bristol-Myers' Damp Squib: Diabetes Drug Onglyza Nets Only $6M in Q4

BNET Pharma

Wed, 02/17/10 - 09:06 am

Bristol-Myers Squibb

Cholesterol-Cutting Drugs Raise Diabetes Risk by 9% in Study

Bloomberg

Wed, 02/17/10 - 08:55 am

Pages